00000000nam 2200000zi 4500
0019.924539
003CaOODSP
00520240513132724
006m     o  d f      
007cr mn|||||||||
008230628e20230711onc     ob   f000 0 eng d
020 |a9780660493053|q(report)
020 |a9780660493060|q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-159/1-2023E-PDF
0861 |aHP5-159/2-2023E-PDF
24500|aGuidance on the use of COVID-19 vaccines in the fall of 2023.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cJuly 11, 2023.
264 4|c©2023
300 |a1 online resource (20 pages) + |e1 summary (4 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in French under title: Directives sur l'utilisation des vaccins contre la COVID-19 à l'automne 2023.
500 |aAt head of title: "An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)."
500 |a"Pub.: 230214."
504 |aIncludes bibliographical references (pages 15-20)..
650 0|aCOVID-19 (Disease)|xVaccination|zCanada.
650 0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tDirectives sur l'utilisation des vaccins contre la COVID-19 à l'automne 2023.|w(CaOODSP)9.924541
85640|qPDF|s400 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-159-1-2023-eng.pdf|zGuidance
85640|qPDF|s248 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-159-2-2023-eng.pdf|zSummary